MANILA, Philippines —A messenger RNA (mRNA) vaccine against the respiratory syncytial virus (RSV), a contagious airborne disease, for adults may be available in the Philippines next year. Dr. Jane Leong, Moderna's vice president for the Asia Pacific region, said that among the vaccines in the company's pipeline to fight against respiratory infections is an RSV jab that is currently in phase 3 clinical trials. The vaccine, however, is specifically designed only for older adults. Moderna is looking to file for regulatory approval in the Philippines once the RSV vaccine is approved in the US and EU, Leong noted.
https://newsinfo.inquirer.net/1779208/jab-vs-respiratory-illness-available-by-next-year#inquirer